Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
Truist Financial
TFC
$64.8B
| $29.3M | 0.01% |
618,700
+4,800
| +0.8% | +$237K |
|
1427
CALL
International Paper
IP
$21.5B
| $29.3M | 0.01% |
699,300
-51,000
| -7% | -$2.37M |
|
1428
Wheaton Precious Metals
WPM
$60.9B
| $29.2M | 0.01% |
810,649
+761,349
| +1,544% | +$33M |
|
1429
Park Hotels & Resorts
PK
$3.05B
| $29.2M | 0.01% |
2,151,627
+1,549,700
| +257% | +$27.4M |
|
1430
CALL
Travelers Companies
TRV
$77.4B
| $29.1M | 0.01% |
172,100
+62,800
| +57% | +$10.9M |
|
1431
Flywire
FLYW
$2.26B
| $29.1M | 0.01% |
1,649,140
+1,047,670
| +174% | +$24.3M |
|
1432
CALL
Boston Beer
SAM
$1.91B
| $29M | 0.01% |
95,800
-6,000
| -6% | -$2.09M |
|
1433
Bloomin' Brands
BLMN
$896M
| $29M | 0.01% |
1,744,918
-387,698
| -18% | -$7.87M |
|
|
SLY
1434
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
| $29M | 0.01% |
361,744
+340,923
| +1,637% | +$29.4M |
|
1435
CALL
Invesco DB Agriculture Fund
DBA
$1.24B
| $28.9M | 0.01% |
1,420,500
+444,100
| +45% | +$9.76M |
|
|
CNH
1436
CNH Industrial
CNH
$16.8B
| $28.9M | 0.01% |
2,494,566
-7,256,722
| -74% | -$103M |
|
|
DAY
1437
DELISTED
Dayforce
DAY
| $28.9M | 0.01% |
613,763
-162,905
| -21% | -$9.04M |
|
1438
Vera Therapeutics
VERA
$2.29B
| $28.9M | 0.01% |
2,122,851
+33,331
| +2% | +$582K |
|
1439
Estee Lauder
EL
$31.5B
| $28.9M | 0.01% |
113,432
-86,251
| -43% | -$21.9M |
|
1440
NovoCure
NVCR
$1.99B
| $28.9M | 0.01% |
415,624
+67,647
| +19% | +$5.1M |
|
1441
iShares Silver Trust
SLV
$31.6B
| $28.9M | 0.01% |
1,548,690
+248,235
| +19% | +$5.18M |
|
1442
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $28.9M | 0.01% |
69,800
+27,500
| +65% | +$12.4M |
|
1443
PUT
HCA Healthcare
HCA
$88.3B
| $28.8M | 0.01% |
171,300
-45,200
| -21% | -$9.71M |
|
1444
Dave & Buster's
PLAY
$353M
| $28.8M | 0.01% |
878,159
+616,056
| +235% | +$24.7M |
|
1445
Douglas Emmett
DEI
$1.96B
| $28.7M | 0.01% |
1,282,414
+39,876
| +3% | +$1.11M |
|
1446
PUT
MGM Resorts International
MGM
$11.1B
| $28.6M | 0.01% |
988,800
-418,400
| -30% | -$15M |
|
1447
CALL
Schwab US Dividend Equity ETF
SCHD
$108B
| $28.6M | 0.01% |
1,197,900
+713,100
| +147% | +$18.1M |
|
1448
PUT
Welltower
WELL
$170B
| $28.6M | 0.01% |
347,100
+30,300
| +10% | +$2.7M |
|
|
SLCR
1449
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
| $28.5M | 0.01% |
2,891,663
+1,082
| +0% | +$10.6K |
|
1450
PUT
Sociedad Química y Minera de Chile
SQM
$21.1B
| $28.5M | 0.01% |
341,200
+140,000
| +70% | +$12.3M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.